Brazilian President Jair Bolsonaro has thanked India for allowing export of raw materials to increase the production of hydroxychloroquine, the anti-malaria drug used to treat the novel coronavirus.
While addressing the nation on Wednesday (8 April), the President said that the country was scheduled to receive a shipment of raw material from India to increase chloroquine production, which is being discussed in the international scientific community about its use and effectiveness, reports Efe news.
With 210 million inhabitants, Brazil has registered 800 deaths from COVID-19, 133 in the last 24 hours, and nearly 16,000 confirmed cases, according to the health ministry's report.
In his address, Bolsonaro thanked "Indian Prime Minister Narendra Modi and the people of India for such timely help to the people of Brazil", adding that as a result of a direct conversation between the two leaders, Brazil will receive "by Saturday, raw materials to continue production of hydroxychloroquine so we can treat patients of COVID-19 as well as of lupus, malaria, and arthritis".
Also on Wednesday and for a second time, US President Donald Trump also thanked Modi for allowing the export of pre-ordered hydroxychloroquine to help his country fight the COVID-19 pandemic.
"I want to thank Prime Minister Modi of India for allowing us to have what we requested from before the problem arose and he was terrific," Trump said at his nationally televised news briefing on Wednesday.
"We will remember it," he added.
This was his second expression of gratitude. Earlier he had tweeted: "Extraordinary times require even closer cooperation between friends. Thank you India and the Indian people for the decision on HCQ. Will not be forgotten! Thank you Prime Minister Narendra Modi for your strong leadership in helping not just India, but humanity, in this fight."
The Modi government had imposed a ban on export of the drug since the coronavirus outbreak hit India.
But on Monday, the Directorate General of Foreign Trade notified lifting restrictions on 14 drugs, including hydroxychloroquine.
Paracetamol and HCQ, have been kept in a licensed category and their demand status was to be continuously monitored. HCQ is being used to treat COVID-19 patients and as prophylactic by the frontline health care workers deployed in the fight against the coronavirus pandemic.
This news has been published via Syndicate feed. Only the headline has been changed.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.